Cargando…

Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability

Up-regulation of the complement component 4A (C4A) in the brain has been associated with excessive synaptic pruning and increased schizophrenia (SZ) susceptibility. Over-expression of C4A has been observed in SZ postmortem brain tissue, and the gene encoding for a protein inhibitor of C4A activity,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hatzimanolis, Alex, Foteli, Stefania, Stefanatou, Pentagiotissa, Ntigrintaki, Angeliki-Aikaterini, Ralli, Irene, Kollias, Konstantinos, Nikolaou, Chrysoula, Gazouli, Maria, Stefanis, Nikos C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508018/ https://www.ncbi.nlm.nih.gov/pubmed/35532796 http://dx.doi.org/10.1007/s00406-022-01409-5

Ejemplares similares

Role of Clinical Insight at First Month in Predicting Relapse at the Year in First Episode of Psychosis (FEP) Patients
por: Vlachos, Ilias I., et al.
Publicado: (2023)

Don’t blame psychosis, blame the lack of services: a message for early intervention from the Greek standard care model
por: Dimitrakopoulos, Stefanos, et al.
Publicado: (2022)

Familial and socioeconomic contributions to premorbid functioning in psychosis: Impact on age at onset and treatment response
por: Hatzimanolis, Alex, et al.
Publicado: (2020)

S125. THE ROLE OF DUP, DUI AND POLYGENIC SCORE FOR SCHIZOPHRENIA ON COGNITION IN ATHENS FEP STUDY SAMPLE
por: Dimitrakopoulos, Stefanos, et al.
Publicado: (2020)

Association between exposome score for schizophrenia and functioning in first-episode psychosis: results from the Athens first-episode psychosis research study
por: Erzin, Gamze, et al.
Publicado: (2023)

Fear of COVID-19 Impact on Professional Quality of Life among Mental Health Workers
por: Stefanatou, Pentagiotissa, et al.
Publicado: (2022)

Longitudinal association between exposome score for schizophrenia and clinical features: results from the Athens First-Episode Psychosis Research Study
por: Erzin, G., et al.
Publicado: (2022)

Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer
por: Escudero-Esparza, Astrid, et al.
Publicado: (2016)

Complement system biomarkers in first episode psychosis
por: Kopczynska, Maja, et al.
Publicado: (2019)

Rare mutations in the complement regulatory gene CSMD1 are associated with male and female infertility
por: Lee, Arthur S., et al.
Publicado: (2019)

Correction: Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer
por: Escudero-Esparza, Astrid, et al.
Publicado: (2023)

Deregulation of CSMD1 targeted by microRNA-10b drives gastric cancer progression through the NF-κB pathway
por: Chen, Xiang-Liu, et al.
Publicado: (2019)

Variation in Psychosis Gene ZNF804A Is Associated With a Refined Schizotypy Phenotype but Not Neurocognitive Performance in a Large Young Male Population
por: Stefanis, Nicholas C., et al.
Publicado: (2013)

Loss of CSMD1 disrupts mammary epithelial morphogenesis
por: Kamal, M, et al.
Publicado: (2010)

The Role of Csmd1 during Mammary Gland Development
por: Burgess, Samuel J., et al.
Publicado: (2021)

Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy
por: Gialeli, Chrysostomi, et al.
Publicado: (2021)

Postsurgical Thrombotic Microangiopathy and Deregulated Complement
por: van Herpt, Thijs T. W., et al.
Publicado: (2022)

Evidence of Cross-Cultural Consistency of the S-Five Model for Misophonia: Psychometric Conclusions Emerging From the Mandarin Version
por: Vitoratou, Silia, et al.
Publicado: (2022)

A Missense Variant in CASKIN1’s Proline-Rich Region Segregates with Psychosis in a Three-Generation Family
por: Wahbeh, Marah H., et al.
Publicado: (2023)

Correction: Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy
por: Gialeli, Chrysostomi, et al.
Publicado: (2023)

Jumping to conclusions bias, psychosis and impulsivity in early stages of Parkinson’s disease
por: Pachi, Ioanna, et al.
Publicado: (2023)

Neuropsychological Deficits in Mice Depleted of the Schizophrenia Susceptibility Gene CSMD1
por: Steen, Vidar M., et al.
Publicado: (2013)

Assessment of Behaviors Modeling Aspects of Schizophrenia in Csmd1 Mutant Mice
por: Distler, Margaret G., et al.
Publicado: (2012)

Altered expression of the CSMD1 gene in the peripheral blood of schizophrenia patients
por: Liu, Yansong, et al.
Publicado: (2019)

Effects of olanzapine on cytokine profile and brain-derived neurotrophic factor in drug-naive subjects with first-episode psychosis
por: Hatziagelaki, Erifili, et al.
Publicado: (2019)

Alternative Complement Pathway Deregulation Is Correlated with Dengue Severity
por: Nascimento, Eduardo J. M., et al.
Publicado: (2009)

Psychopathological Determinants of Quality of Life in People with Borderline Personality Disorder
por: Stefanatou, Pentagiotissa, et al.
Publicado: (2022)

Cognitive ability and metabolic physical health in first-episode psychosis
por: Whitson, Sarah, et al.
Publicado: (2021)

Deregulation of Rho GTPases in cancer
por: Porter, Andrew P., et al.
Publicado: (2016)

Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines
por: Richter, Toni M, et al.
Publicado: (2005)

Genetic Variants in CSMD1 Gene Are Associated with Cognitive Performance in Normal Elderly Population
por: Stepanov, Vadim, et al.
Publicado: (2017)

CSMD3 is Associated with Tumor Mutation Burden and Immune Infiltration in Ovarian Cancer Patients
por: Lu, Nan, et al.
Publicado: (2021)

Association of CSMD1 with Tumor Mutation Burden and Other Clinical Outcomes in Gastric Cancer
por: Wang, Xuning, et al.
Publicado: (2021)

The Diverse Role of CUB and Sushi Multiple Domains 1 (CSMD1) in Human Diseases
por: Ermis Akyuz, Esra, et al.
Publicado: (2022)

mRNA Expression of the CUB and Sushi Multiple Domains 1 (CSMD1) and Its Serum Protein Level as Predictors for Psychosis in the Familial High-Risk Children and Young Adults
por: Abd El Gayed, Eman Masoud, et al.
Publicado: (2021)

Associations Between Genotype and Peripheral Complement Proteins in First-Episode Psychosis: Evidences From C3 and C4
por: Chen, Yu, et al.
Publicado: (2021)

Association of RGS4 variants with schizotypy and cognitive endophenotypes at the population level
por: Stefanis, Nicholas C, et al.
Publicado: (2008)

Csmd2 Is a Synaptic Transmembrane Protein that Interacts with PSD-95 and Is Required for Neuronal Maturation
por: Gutierrez, Mark A., et al.
Publicado: (2019)

Whole-exome sequencing associates novel CSMD1 gene mutations with familial Parkinson disease
por: Ruiz-Martínez, Javier, et al.
Publicado: (2017)

LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling
por: Liu, Ji, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eqdnq2vj04v5me8tmee58bhjcr